Brief: Bergenbio Q3 Oper Loss Widens To NOK 70.5 Mln

Oncoinvent ASA

16/11/2021 06:29

Nov 16 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * Q3 OPERATING LOSS -70.5 MILLION NOK VERSUS -67.3 MILLION
NOK
LOSS YEAR AGO
    * Q3 TOTAL OPERATING EXPENSES WERE NOK 71.4 MILLION (Q3
2020: NOK
68.3 MILLION)
    * Q3 OPERATING LOSS OF NOK 70.5 MILLION, DECREASED COMPARED
TO
PREVIOUS QUARTERS, (Q3 2020: NOK 67.3 MILLION)

Source text for Eikon:  ID:nObiM55gHa 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))